Desterke C, Fu Y, Bonifacio-Mundaca J, Monge C, Pineau P, Mata-Garrido J
Curr Oncol. 2025; 32(1).
PMID: 39851951
PMC: 11763369.
DOI: 10.3390/curroncol32010035.
Minaeva M, Domingo J, Rentzsch P, Lappalainen T
NAR Genom Bioinform. 2025; 7(1):lqae178.
PMID: 39781510
PMC: 11704787.
DOI: 10.1093/nargab/lqae178.
Monge C, Frances R, Marchio A, Pineau P, Desterke C, Mata-Garrido J
Int J Mol Sci. 2024; 25(23).
PMID: 39684755
PMC: 11641740.
DOI: 10.3390/ijms252313044.
Wu P, Fish M, Hazard F, Zhu C, Vennam S, Walton H
Nat Commun. 2024; 15(1):10007.
PMID: 39567523
PMC: 11579301.
DOI: 10.1038/s41467-024-53802-4.
Aguiar T, Rivas M, Silva E, Pires S, Dangoni G, Macedo T
Biochem Genet. 2024; .
PMID: 38649558
DOI: 10.1007/s10528-024-10764-y.
Domain generalization enables general cancer cell annotation in single-cell and spatial transcriptomics.
Zhong Z, Hou J, Yao Z, Dong L, Liu F, Yue J
Nat Commun. 2024; 15(1):1929.
PMID: 38431724
PMC: 10908802.
DOI: 10.1038/s41467-024-46413-6.
Specifying cellular context of transcription factor regulons for exploring context-specific gene regulation programs.
Minaeva M, Domingo J, Rentzsch P, Lappalainen T
bioRxiv. 2024; .
PMID: 38260658
PMC: 10802353.
DOI: 10.1101/2023.12.31.573765.
EZH2 is a key component of hepatoblastoma tumor cell growth.
Glaser K, Schepers E, Zwolshen H, Lake C, Timchenko N, Karns R
Pediatr Blood Cancer. 2023; 71(2):e30774.
PMID: 37990130
PMC: 10842061.
DOI: 10.1002/pbc.30774.
expression is elevated in hepatoblastoma and correlates with inferior patient survival.
Nousiainen R, Eloranta K, Isoaho N, Cairo S, Wilson D, Heikinheimo M
Front Genet. 2023; 14:1170940.
PMID: 37377594
PMC: 10291054.
DOI: 10.3389/fgene.2023.1170940.
GepLiver: an integrative liver expression atlas spanning developmental stages and liver disease phases.
Li Z, Zhang H, Li Q, Feng W, Jia X, Zhou R
Sci Data. 2023; 10(1):376.
PMID: 37301898
PMC: 10257690.
DOI: 10.1038/s41597-023-02257-1.
Applications of single-cell RNA sequencing in drug discovery and development.
Van de Sande B, Lee J, Mutasa-Gottgens E, Naughton B, Bacon W, Manning J
Nat Rev Drug Discov. 2023; 22(6):496-520.
PMID: 37117846
PMC: 10141847.
DOI: 10.1038/s41573-023-00688-4.
Structural and Functional Impact of Posttranslational Modification of Glypican-3 on Liver Carcinogenesis.
Schepers E, Glaser K, Zwolshen H, Hartman S, Bondoc A
Cancer Res. 2023; 83(12):1933-1940.
PMID: 37027004
PMC: 10267680.
DOI: 10.1158/0008-5472.CAN-22-3895.
CRISPR-induced exon skipping of β-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer.
Mou H, Eskiocak O, Ozler K, Gorman M, Yue J, Jin Y
J Pathol. 2023; 259(4):415-427.
PMID: 36641763
PMC: 10273193.
DOI: 10.1002/path.6054.
SPEED: Single-cell Pan-species atlas in the light of Ecology and Evolution for Development and Diseases.
Chen Y, Zhang X, Peng X, Jin Y, Ding P, Xiao J
Nucleic Acids Res. 2022; 51(D1):D1150-D1159.
PMID: 36305818
PMC: 9825432.
DOI: 10.1093/nar/gkac930.
Inhibition of Glypican-3 Cleavage Results in Reduced Cell Proliferation in a Liver Cancer Cell Line.
Schepers E, Lake C, Glaser K, Bondoc A
J Surg Res. 2022; 282:118-128.
PMID: 36272230
PMC: 10893758.
DOI: 10.1016/j.jss.2022.09.011.
The Cellular and Molecular Landscape of Synchronous Pediatric Sialoblastoma and Hepatoblastoma.
Yang R, Zhan Y, Li Y, Dai S, He S, Ye C
Front Oncol. 2022; 12:893206.
PMID: 35860547
PMC: 9289541.
DOI: 10.3389/fonc.2022.893206.
Surgical Pathology Diagnostic Pitfalls of Hepatoblastoma.
Auld F, Sergi C
Int J Surg Pathol. 2022; 30(5):480-491.
PMID: 35048730
PMC: 9260486.
DOI: 10.1177/10668969211070178.
Establishment of childhood hepatoblastoma xenografts and evaluation of the anti-tumour effects of anlotinib, oxaliplatin and sorafenib.
Yang D, Chen F, Gong D, Zeng L, Xiang D, He Y
Pediatr Surg Int. 2022; 38(3):465-472.
PMID: 35032209
DOI: 10.1007/s00383-021-05043-5.